secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pharma-Bio Serv, Inc. (PBSV)
CIK:        0001304161
Form:       8-K
Filed at:   2026-05-15T21:02:05+00:00
Accession:  0001654954-26-005006
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pharma-Bio Serv annual meeting elects Irving Wiesen as Class I director
-----------------------------------------------------------------------

- Irving Wiesen elected with 10,208,071 votes for and 195,625 withheld; 2,839,645 broker non-votes.
- Ratification of Crowe PR PSC as independent auditor for FY ending Oct 31, 2026: 13,241,794 for, 3 against, 1,544 abstain.
- No other proposals or material events disclosed at the May 15, 2026 Annual Meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1304161/000165495426005006/0001654954-26-005006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1304161/000165495426005006/pbsv_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-26-005006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer